
	Three months ended September 30, 2026						Three months ended September 30, 2025
	U.S. dialysis		Other — Ancillary services		Consolidated		U.S. dialysis		Other — Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage	$	1,756,098	$		$	1,756,098	$	1,715,224	$		$	1,715,224
Medicaid and Managed Medicaid	228,173				228,173		214,658				214,658
Other government	89,887		252,760		342,647		86,996		237,627		324,623
Commercial	969,474		133,882		1,103,356		956,887		98,630		1,055,517
Other revenues:
Medicare and Medicare Advantage			137,027		137,027				85,877		85,877

Commercial			4,265		4,265				3,762		3,762
Other(1)	6,846		23,832		30,678		6,275		28,994		35,269
Eliminations of intersegment revenues	(22,008)		(2,110)		(24,118)		(11,932)		(2,771)		(14,703)
Total	$	3,028,470	$	549,656	$	3,578,126	$	2,968,108	$	452,119	$	3,420,227


	Nine months ended September 30, 2026						Nine months ended September 30, 2025
	U.S. dialysis		Other — Ancillary services		Consolidated		U.S. dialysis		Other — Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage	$	5,180,801	$		$	5,180,801	$	4,983,850	$		$	4,983,850
Medicaid and Managed Medicaid	667,947				667,947		638,865				638,865
Other government	271,675		737,316		1,008,991		246,846		672,928		919,774
Commercial	2,863,944		379,598		3,243,542		2,828,790		277,057		3,105,847
Other revenues:
Medicare and Medicare Advantage			397,776		397,776				324,981		324,981
Medicaid and Managed Medicaid			—		—				2		2
Commercial			14,153		14,153				14,786		14,786
Other(1)	19,636		77,238		96,874		18,248		65,647		83,895
Eliminations of intersegment revenues	(53,841)		(8,485)		(62,326)		(40,382)		(8,336)		(48,718)
Total	$	8,950,162	$	1,597,596	$	10,547,758	$	8,676,217	$	1,347,065	$	10,023,282

(1) Consists primarily of management service fees in the Company's U.S. dialysis business and research fees, management fees, and other non-patient service revenues in the Other - ancillary services businesses.